Immunovia AB (publ) ("Immunovia" or the "Company") hereby announces that the exercise price for warrants series TO 2 (the "warrants") has been determined to SEK 0.46. The exercise period for the ...
Rapid progress in synthetic biology and genetic engineering drives demand for DNA synthesis to design novel biological systems. Research and Development (R&D) Investments: Increasing investments in ...
The end of a year provides an ideal opportunity for revisiting the previous year’s goals and performance, reviewing personal and professional aspirations, ...